| Role of Endothelial Cells in Acute and Chronic Thrombosis |
9 |
| Follow-up after acute Pulmonary Embolism: Predicting chronic thromboembolic pulmonary hypertension and post-pulmonary embolism syndrome |
7 |
| Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis |
6 |
| Lemierre Syndrome: Clinical Update and Protocol for a Systematic Review and Individual Patient Data Meta-analysis |
6 |
| Platelet Signaling in Primary Haemostasis and Arterial Thrombus Formation: Part 1 |
5 |
| Impact of Telemedicine Tools on Record Keeping and Compliance in Haemophilia Care |
5 |
| New Insights into Platelet Signalling Pathways by Functional and Proteomic Approaches |
4 |
| Anticoagulation in Atherosclerotic Disease |
4 |
| Repeated Administration of Idarucizumab to a Patient with Dabigatran Overdose |
4 |
| Pseudoaneurysm Incidence, Therapy and Complications |
3 |
| Laboratory Diagnostics in Thrombophilia |
3 |
| Low-Molecular-Weight Heparin in Cancer Patients: Overview and Indications |
3 |
| Epidemiology and Treatment of Patients with Haemophilia in Austria-Update from the Austrian Haemophilia Registry |
3 |
| Diagnosing Immune Thrombocytopenia |
3 |
| Epidemiology and Clinical Manifestations of Immune Thrombocytopenia |
3 |
| Optimizing the Personalized, Risk-Adjusted Management of Pulmonary Embolism: An Integrated Clinical Trial Programme |
3 |
| Coagulation Signalling and Metabolic Disorders: Lessons Learned from Animal Models |
2 |
| The Gut Microbiota as an Influencing Factor of Arterial Thrombosis |
2 |
| Thromboinflammation and Vascular Dysfunction |
2 |
| The Mutual Relation of Platelet Activation and Innate Immunity |
2 |
| Management of Helicobacter pylori in Patients with Immune Thrombocytopenia |
2 |
| Thrombopoietin Receptor Agonist Use for Immune Thrombocytopaenia |
2 |
| First-Line Therapy for Immune Thrombocytopenia |
2 |
| Apixaban for the Treatment of Chronic Disseminated Intravascular Coagulation: A Report of Two Cases |
2 |
| Therapy of the Antiphospholipid Syndrome (APS) with DOAKs Statement of the scientific Societies GTH, DGA, DGP as well as of BDDH and German Vascular Conference and the Action Alliance Thrombosis on the Red Hand Letter from 23.05.2019 |
2 |
| Smart Medication ((TM)) , an Electronic Diary for Surveillance of Haemophilia Home Care and Optimization of Resource Distribution |
2 |
| Prevalence of Obesity in Young Patients with Severe Haemophilia and Its Potential Impact on Factor VIII Consumption in Germany |
2 |
| Feasibility and Results of a Mobile Haemophilia Outpatient Care Pilot Project |
2 |
| The Impact of Bleeding Disorders on the Socioeconomic Status of Adult Patients Results of a comparative single centre cohort study |
2 |
| Trauma-Induced Coagulopathy |
2 |
| MYH9-Related Thrornbocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the Disorder |
2 |
| Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen |
1 |
| The Role of Low Molecular Weight Heparins for Venous Thromboembolism Prevention in Medical Patients-What Is New in 2019? |
1 |
| Microvascular Thrombosis and Ischaemic Limb Losses in Critically Ill Patients |
1 |
| Platelet Signaling in Primary Haemostasis and Arterial Thrombus Formation: Part 2 |
1 |
| The Involvement of Toll-like Receptor-2 in Arterial Thrombus Formation |
1 |
| Reperfusion Treatment for Acute Pulmonary Embolism |
1 |
| Immunomodulatory Second-Line Therapies for Immune Thrombocytopenia |
1 |
| Guideline of the Society for Thrombosis- and Hemostasis Research (GTH) on the Structure- and Process Quality of Hemophilia Centers |
1 |
| Long-Term Safety and Efficacy Data of a Plasma-Derived Factor VIII Concentrate with von Willebrand Factor for Treatment of Patients with Hemophilia A Covering 18 Years |
1 |
| Functional Classification of Paediatric Patients with Non-syndromic Delta-Storage Pool Deficiency |
1 |
| Fulminant Essential Thrombocythemia Associated with Acquired Von Willebrand Syndrome and Bleeding Episodes in a 14-year-old Girl |
1 |
| Diagnosis of acute Pulmonary Embolism |
1 |
| Cofactor-Independent Antiphospholipid Antibodies: Implications for Pathogenesis, Diagnosis, and Treatment of Antiphospholipid Syndrome |
1 |
| Acute Transmural Myocardial Infarction by Coronary Embolism in a Patient with JAK2 V617F-Positive Essential Thrombocythemia |
1 |
| Current Information on the Vote on 28.06.2019 on the Law for more Safety in the Drug Supply (GSAV) in the Federal Council of Germany |
0 |
| Characterization and Diagnostic Work-up of a Patient with Functionally Impaired Platelet GP6 |
0 |
| 49th Hamburg Hemophilia Symposium Hamburg, Germany, November 9- 2018 Abstracts |
0 |
| Antiphospholipid Antibodies in a General Obstetric Population: Clinical Impact on Pregnancy Outcome and Relationship with the M2 Haplotype in the Annexin A5 ( ANXA5 ) Gene |
0 |
| Endothelial Function in Patients with Severe and Moderate Haemophilia A and B |
0 |
